Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 1.220
-0.020 (-1.61%)
May 16, 2025, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 529.72 million as of May 16, 2025. Its market cap has increased by 36.06% in one year.
Market Cap
529.72M
Enterprise Value
513.04M
Revenue
5.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.22
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 529.72M, a decrease of -93.33%. That is a compound annual growth rate of -41.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 529.72M | 26.13% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | 3.86B | -51.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 192.85B |
| Hansoh Pharmaceutical Group Company | 139.43B |
| JD Health International | 124.72B |
| WuXi Biologics | 95.65B |
| Alibaba Health Information Technology | 84.43B |
| Innovent Biologics | 84.13B |
| Akeso | 74.95B |
| Sino Biopharmaceutical | 72.47B |